ALRTF — ALR Technologies SG Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $7.98m
- $28.61m
- $0.01m
Annual income statement for ALR Technologies SG, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0.007 |
| Cost of Revenue | |||||
| Gross Profit | — | — | — | — | 0.005 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1.07 | 2.18 | 3.74 | 3.83 | 2.98 |
| Operating Profit | -1.07 | -2.18 | -3.74 | -3.83 | -2.97 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.84 | -4.12 | -9.01 | -5.92 | -8.44 |
| Net Income After Taxes | -2.84 | -4.12 | -9.01 | -5.92 | -8.44 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.84 | -4.12 | -9.01 | -5.92 | -8.44 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.84 | -4.12 | -9.01 | -5.92 | -8.44 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.012 | -0.017 | -0.035 | -0.018 | -0.016 |